|
ZNF471 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00939265226907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.34212649274923E-12 |
| Normal-vs-Stage2 |
5.91170445929379E-11 |
| Normal-vs-Stage3 |
1.63513647066793E-12 |
| Normal-vs-Stage4 |
3.10640402290119E-11 |
| Stage1-vs-Stage2 |
7.633200E-01 |
| Stage1-vs-Stage3 |
2.271600E-02 |
| Stage1-vs-Stage4 |
4.385600E-01 |
| Stage2-vs-Stage3 |
1.830360E-01 |
| Stage2-vs-Stage4 |
7.124800E-01 |
| Stage3-vs-Stage4 |
3.899400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89626092605977E-13 |
| Normal-vs-AfricanAmerican |
1.22400000002187E-06 |
| Normal-vs-Asian |
2.30890000452177E-08 |
| Caucasian-vs-AfricanAmerican |
4.472400E-01 |
| Caucasian-vs-Asian |
3.340500E-02 |
| AfricanAmerican-vs-Asian |
4.647000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73117076229801E-12 |
| Normal-vs-Female |
2.00039984576961E-12 |
| Male-vs-Female |
7.737800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.57227572575403E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
2.25153229393982E-13 |
| Normal-vs-Age(81-100Yrs) |
3.555300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.214400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.107200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.805800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.275400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.285000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.997800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.62860999999292E-05 |
| Classical-VS-Follicular |
2.058000E-01 |
| Classical-VS-Other |
4.281200E-01 |
| Classical-VS-Normal |
2.90000246039313E-11 |
| Tall-VS-Follicular |
1.809950E-02 |
| Tall-VS-Other |
9.990200E-02 |
| Tall-VS-Normal |
1.62536650805123E-12 |
| Follicular-VS-Other |
3.072000E-01 |
| Follicular-VS-Normal |
1.91668902971287E-12 |
| Other-VS-Normal |
1.703630E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.78141962187328E-13 |
| Normal-vs-N1 |
4.09629996589445E-10 |
| N0-vs-N1 |
5.276600E-01 |
|
|
